Invatec Receives FDA Clearance For Mo.Ma(R) Ultra Proximal Cerebral Protection Device
Main Category: Neurology / Neuroscience Also Included In: Regulatory Affairs / Drug Approvals ; Medical Devices / Diagnostics ; Stroke Article Date: 23 Oct 200919:00 PDT Invatec, a comprehensive innovator of interventional products, announced that it has received 510 clearance from the U.S. Food and Drug Administration to market its Mo.Ma Ultra …
source : www.topix.com
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Related News:
- Abbott Receives U.S. FDA Approval For New Cataract Multifocal Intraocular Lens
- Novo Nordisk Receives FDA Approval For Norditropin® FlexPro® For Growth Hormone Treatment
- OrthoDynamix LLC Receives FDA 510(k) Clearance For ArthroSteer(R) 3.5mm Ablator
- Sunridge Receives Approval For Its Non-Invasive Glaucoma Treatment In China
- Paloma Pharmaceuticals Receives Approval To Enter Phase I Clinical Trials
- Pervasis Therapeutics Receives FDA Clearance For Pivotal Phase 3 Trial Of Vascugel(R)
- Repros Receives Guidance From FDA Regarding Continued Development Of Androxal(R) In Hypogonadal Men
- Teva Receives Favorable Court Decision Regarding Generic Temodar(R)
- Glaucoma Research: IU Optometry’s Swanson Receives $2.35 Million From NIH
- Amgen Receives CHMP Positive Opinion For Prolia(TM) (Denosumab) In The European Union
Details :
Submited at Saturday, October 24th, 2009 at 12:00 pm on Neurology by admin
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















